Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Depreciation Expense: 2012-2020

Historic Depreciation Expense for Ani Pharmaceuticals (ANIP) over the last 9 years, with Dec 2020 value amounting to $1.3 million.

  • Ani Pharmaceuticals' Depreciation Expense rose 8.33% to $1.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was $4.9 million, marking a year-over-year increase of 6.52%. This contributed to the annual value of $7.4 million for FY2024, which is 1.33% down from last year.
  • Ani Pharmaceuticals' Depreciation Expense amounted to $1.3 million in Q4 2020, which was up 8.33% from $1.2 million recorded in Q3 2020.
  • Over the past 5 years, Ani Pharmaceuticals' Depreciation Expense peaked at $1.3 million during Q4 2020, and registered a low of $200,000 during Q1 2016.
  • In the last 3 years, Ani Pharmaceuticals' Depreciation Expense had a median value of $1.1 million in 2019 and averaged $966,667.
  • Data for Ani Pharmaceuticals' Depreciation Expense shows a peak YoY surged of 300.00% (in 2019) over the last 5 years.
  • Over the past 5 years, Ani Pharmaceuticals' Depreciation Expense (Quarterly) stood at $200,000 in 2016, then spiked by 50.00% to $300,000 in 2017, then surged by 166.67% to $800,000 in 2018, then surged by 50.00% to $1.2 million in 2019, then climbed by 8.33% to $1.3 million in 2020.
  • Its Depreciation Expense was $1.3 million in Q4 2020, compared to $1.2 million in Q3 2020 and $1.2 million in Q2 2020.